Advertisement
Screener

GT BIOPHARMA, INC. (GTBP) Net Margin

GT BIOPHARMA, INC. (GTBP) Net Margin

  • 2015-06-30: Net Margin 134300.00%.
  • 2015-03-31: Net Margin -293085.71%.
  • 2014-12-31: Net Margin -56472.73%.
  • 2014-09-30: Net Margin -140666.67%.

Complete source-backed net margin history.

Available history
2010-12-31 to 2015-12-31
Data captured

Historical Net Margin

DateNet Margin
2015-06-30134300.00%
2015-03-31-293085.71%
2014-12-31-56472.73%
2014-09-30-140666.67%
2014-06-30-1048.00%
2013-12-31-863.41%
2013-09-30-174.32%
2013-06-30-174.32%
2013-03-31531.82%
2012-12-31-347.49%
2012-09-30-1166.67%
2012-06-30-239500.00%
2012-03-31-61500.00%
2011-12-31-37933.33%
2011-09-301150.00%
2011-03-31-9615.00%
2010-12-31-6018.18%

Annual Net Margin

DateNet Margin
2015-12-31-121207.41%
2014-12-31-38506.56%
2013-12-31-136.14%
2012-12-31-1511.99%
2011-12-31-14230.77%
2010-12-31-27227.27%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Evommune, Inc. (EVMN)United States$0.320B-5.10
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88